Intravenous urocortin II decreases blood pressure through CRF2 receptor in rats

Regulatory Peptides

Volumn 113, Issue 1-3, 2003, Pages 125-130

  Chen, Chih Yen ^a,c   Doong, Ming Luen ^a,c   Rivier, Jean E ^b   Taché, Yvette ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Astressin2 B; Blood pressure; CRF2 receptor; Human urocortin II; Hypotension; Rats; RX 77368; Urocortin

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; ISOPROTEIN; PROTIRELIN[3 (3,3 DIMETHYLPROLINAMIDE)]; URETHAN; UROCORTIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC REFLEX;

EID: 0037447760     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00003-X     Document Type: Article

References (34)

1. Arancibia S., Rage F., Astier H., Tapia-Arancibia L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology. 64:1996;257-267.
2. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E.et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24:2000;410-414.
3. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H.et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24:2000;403-409.
4. Feuerstein G., Hassen A.H., Faden A.I. TRH: cardiovascular and sympathetic modulation in brain nuclei of the rat. Peptides. 4:1983;617-620.
5. Hashimoto K., Makino S., Asaba K., Nishiyama M. Physiological roles of corticotropin-releasing hormone receptor type 2. Endocr. J. 48:2001;1-9.
6. Hermus A.R., Pieters G.F., Willemsen J.J., Ross H.A., Smals A.G., Benraad T.J.et al. Hypotensive effects of ovine and human corticotrophin-releasing factors in man. Eur. J. Clin. Pharmacol. 31:1987;531-534.
7. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7:2001;605-611.
8. Jain V., Longo M., Ali M., Saade G.R., Chwalisz K., Garfield R.E. Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J. Soc. Gynecol. Investig. 7:2000;153-160.
9. Kanamoto K., Urdaneta A., Rivier J., Taché Y. Intravenous urcorotin II induced gastroprotection and gastric hyperemia in anesthetized rats: role of CRF receptor 2. Gastroenterology. 122:2002;A-13.
10. Király Á., Süto G., Guth P.H., Taché Y. Peripheral mediators involved in gastric hyperemia to vagal activation by central TRH analog in rats. Am. J. Physiol. 274:1998;G170-G177.
11. Király Á., Süto G., Livingston E.H., Guth P.H., St.Pierre S., Taché Y. Central vagal activation by TRH induces gastric hyperemia: role of CGRP in capsaicin-sensitive afferents in rats. Am. J. Physiol. 267:1994;G1041-G1049.
12. Lei S., Richter R., Bienert M., Mulvany M.J. Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br. J. Pharmacol. 108:1993;941-947.
13. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C.et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7570-7575.
14. Lovenberg T.W., Chalmers D.T., Liu C., De Souza E.B. CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:1995;4139-4142.
15. Lubomirov L., Gagov H., Petkova-Kirova P., Duridanova D., Kalentchuk V.U., Schubert R. Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium. Br. J. Pharmacol. 134:2001;1564-1570.
16. Maillot C., Million M., Wei J.Y., Gauthier A., Taché Y. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology. 119:2000;1569-1579.
17. Martinez V., Wang L., Rivier J., Vale W., Taché Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther. 301:2002;611-617.
18. Martinez V., Wu S.V., Taché Y. Intracisternal antisense oligodeoxynucleotides to the thyrotropin-releasing hormone receptor blocked vagal-dependent stimulation of gastric emptying induced by acute cold in rats. Endocrinology. 139:1998;3730-3735.
19. 2-mediated action on gastric transit in rats. Am. J. Physiol., Gastrointest. Liver Physiol. 282:2002;G34-G40.
20. Nurminen M.L., Paakkari I. Role of peripheral and central catecholaminergic and cholinergic mechanisms in the cardiovascular effects of thyrotropin-releasing hormone. Neuropeptides. 20:1991;247-253.
21. Overton J.M., Fisher L.A. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats. J. Auton. Nerv. Syst. 35:1991;43-51.
22. Parkes D.G., Weisinger R.S., May C.N. Cardiovascular actions of CRH and urocortin: an update. Peptides. 22:2001;821-827.
23. Perrin M.H., Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann. N. Y. Acad. Sci. 885:1999;312-328.
24. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A.et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2843-2848.
25. Richter R.M., Mulvany M.J. Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral, and in vitro application. Peptides. 16:1995;843-849.
26. Rivier J., Gulyas J., Kirby D., Low W., Perrin M.H., Kunitake K.et al. Potent and long acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J. Med. Chem. 45:2002;4737-4747.
27. Rohde E., Furkert J., Fechner K., Beyermann M., Mulvany M.J., Richter R.M.et al. Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol. 52:1996;829-833.
28. Ruhmann A., Bonk I., Lin C.R., Rosenfeld M.G., Spiess J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2β-selective antisauvagine-30. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15264-15269.
29. Sanz E., Monge L., Fernandez N., Martinez M.A., Martinez-Leon J.B., Dieguez G.et al. Relaxation by urocortin of human saphenous veins. Br. J. Pharmacol. 136:2002;90-94.
30. Schilling L., Kanzler C., Schmiedek P., Ehrenreich H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Br. J. Pharmacol. 125:1998;1164-1171.
31. Sirén A.L., Lake C.R., Feuerstein G. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ. Res. 62:1988;139-154.
32. Taché Y., Yang H. Role of medullary TRH in the regulation of gastric function. Taché Y., Wingate D.L., Burks T.F. Innervation of the gut: pathophysiological implications. 1993;67-80 CRC Press, Boca Raton.
33. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S.et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
34. Wang L., Martinez V., Rivier J.E., Taché Y. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am. J. Physiol., Regul. Integr. Comp. Physiol. 281:2001;R1401-R1410.